Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is one of the more common things people notice in the first weeks on Mounjaro (tirzepatide). It usually settles as your body adjusts to the medicine, and for most people it is temporary — but knowing why it happens, and the handful of things that can make it worse, makes it much easier to manage. As a prescription-only medicine, Mounjaro is dispensed only after a prescriber has assessed your suitability; if tiredness feels severe or is getting worse rather than better, your prescriber is the right person to contact.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works on two gut-hormone pathways (GLP-1 and GIP) that slow how quickly the stomach empties and signal fullness to the brain. The result is a meaningful drop in calorie intake, sometimes quite sharp in the first few weeks. Your body has run on a certain fuel supply for years; when that drops, energy levels often follow. If you want a deeper look at what being tired on Mounjaro actually involves and why it happens, we have covered the full picture in one place. This is the same biological logic behind feeling sluggish on any calorie-restricted eating plan.
On top of that, tirzepatide can cause nausea, reduced appetite, and occasional vomiting, particularly when nausea is prominent. Eating and drinking less than usual compounds the fatigue directly. Blood sugar also shifts, and even in people without diabetes, GIP and GLP-1 activity nudges glucose metabolism, which can leave you feeling flat. The NHS tirzepatide medicines page lists fatigue as a recognised side effect, which means it has shown up consistently enough across clinical use to warrant inclusion in the official patient information.
None of this means something has gone wrong. It means the medicine is doing what it is licensed to do, and your system is responding.
Yes, and the pattern is fairly predictable. Most people notice it most in the first one to two weeks at a new dose, including the very first pen at 2.5 mg. The starter dose exists specifically to ease your body in gradually, the tiredness at that stage is partly just adjustment.
After each dose increase the same temporary dip can return. If you track your energy levels even loosely (a quick note on your phone each morning rates your fatigue out of ten) you will usually spot that the worst days cluster in the first week after a change and then improve. That pattern, spotted early, is genuinely reassuring. For detailed thoughts on why fatigue follows dose changes the way it does, our prescribers have covered the mechanism in more depth.
If the fatigue is not following that settling arc (if it is flat-lining at a high level or worsening after week two or three without a recent dose step) that is worth mentioning to your prescriber. It may simply be that protein or fluid intake has dipped, but it warrants a proper look.
Protein is the practical priority. When appetite drops sharply, people often cut calories but also inadvertently reduce protein, which the body relies on for sustained energy. Aiming to keep protein at or above your usual intake (eggs, fish, Greek yoghurt, legumes, whatever fits your appetite) tends to make a bigger difference to energy than almost anything else.
Fluid intake matters too. Nausea can make plain water unappealing, but even mild dehydration amplifies tiredness significantly. Small sips, consistently, across the day. Some people find electrolyte drinks helpful during the nausea phase, though plain water is fine for most.
Sleep quality sometimes shifts on GLP-1 medicines, lighter or more interrupted sleep is reported anecdotally, though the evidence here is thinner than for GI side effects. If you are sleeping less well than usual, that alone can account for a lot of the daytime fatigue. Light activity (a short walk rather than the gym) generally helps more than rest at this stage, though rest wins on the worst days.
Worth avoiding: alcohol (it compounds fatigue directly) and very low-calorie days in pursuit of faster results. The medicine is already creating a meaningful deficit; extreme restriction on top of that pushes the body into a state it finds very hard to sustain. Our full side-effects guide for Mounjaro covers the broader picture if you are managing several things at once.
Most tiredness on Mounjaro is benign and self-limiting. There are situations, though, where it signals something that needs prompt attention. Contact your prescriber or GP if fatigue is severe and not improving after two to three weeks at a stable dose, or if it is accompanied by any of the following: severe or persistent stomach pain (especially pain that spreads to your back), repeated vomiting that is preventing you from keeping fluids down, signs of dehydration such as dizziness when you stand up, significant low mood or thoughts of self-harm, or a yellowing of the skin or eyes.
The MHRA Drug Safety Updates include specific guidance on recognising serious GI events (including pancreatitis) where persistent abdominal pain is the key warning sign. It is a low-probability event, but one that is worth knowing about.
If you are already being treated through a regulated pharmacy and have questions about your specific situation, the aftercare team at nume is available seven days a week. Separately, patients can report any suspected side effects directly at the MHRA Yellow Card scheme.
If you are still considering whether Mounjaro is right for you and want to understand the full picture before starting, our Mounjaro overview sets out what the treatment involves from the beginning. And if cost is part of the conversation, a plain account of how Mounjaro is priced privately in the UK is worth a read before you compare options. When you are ready to take the next step, check your eligibility with our prescribers, it costs nothing and your application is reviewed the same day by a real clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.